Treasury poised to propose added scrutiny of U.S.-China biotech licensing deals
The U.S. Department of the Treasury is poised to issue a proposed rule that would subject outbound U.S. licensing deals with Chinese biotechnology companies to additional regulatory scrutiny under the COINS Act. STAT, citing Endpoints News, reported on…
